Metabolomics Market Share

Asia Pacific Market Forecast

The Asia Pacific metabolomics market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037, on the back of increasing demand for pharmaceutical and biopharmaceutical products developed in the regions of developing countries such as India and China. The demand for better medical care, government initiatives, healthcare awareness, and technological improvements are estimated to boost the market during the forecast period. The government of Japan issued more than USD 8 million to UNICEF East Asia and Pacific Regional Office to assist with digital immunization tools in Cambodia, Lao PDR, Mongolia, the Philippines, Timor-Leste, and Vietnam. These interventions indirectly reached about 13 million people along with over 1000 health facilities and more than 4000 health workers.